Eli Lilly (LLY) Director Purchases 1,565 Shares at ~$642

Rhea-AI Filing Summary

On 08/12/2025, Director J. Erik Fyrwald reported purchases of Eli Lilly & Co. (LLY) common stock totaling 1,565 shares across two transactions: 686 shares at a weighted average price of $641.996 and 879 shares at $642.586. The Form 4 shows beneficial ownership rising to 73,698.779 shares after the first purchase and to 74,577.779 shares after the second. The filing notes the reported prices are weighted averages across multiple executions within disclosed price ranges and offers to provide detailed per-price execution data on request.

Insights

Financial Analyst

TL;DR: A director bought 1,565 LLY shares at roughly $642 each; size is modest relative to company scale.

The purchases total 1,565 shares executed on 08/12/2025 in two tranches at disclosed weighted average prices of $641.996 and $642.586. While director purchases can signal confidence, the absolute size (1,565 shares, roughly $1.0M at the reported prices) is small relative to Eli Lilly's market capitalization and does not by itself indicate a material change to ownership or control. The Form 4 properly discloses weighted-average pricing and offers to provide transaction-level details.

Corporate Governance Expert

TL;DR: Disclosure is complete for Section 16 purposes; the transaction appears routine and non-material.

The Form 4 lists clear purchase codes and weighted-average prices and shows the reporting person as a Director. The statement that more granular execution data is available on request is consistent with transparency best practices. There are no indications of derivative transactions, option exercises, or changes in control. From a governance perspective this is a routine insider purchase disclosure with no material governance concerns disclosed in the document.

Insider Trade Summary

Net Buyer: 1,565 shares ($1,005,242)

Net Buy 2 txns

Insider Fyrwald J Erik

Role Director

Bought 1,565 shs ($1.01M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	686	$641.996	$440K
Purchase	Common Stock	879	$642.586	$565K

Holdings After Transaction: Common Stock — 73,698.779 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fyrwald J Erik

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		P		686	A	$641.996(1)	73,698.779	D
Common Stock	08/12/2025		P		879	A	$642.586(1)	74,577.779	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Jonathan Groff for J. Erik Fyrwald, pursuant to authorization on file	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did J. Erik Fyrwald report on the LLY Form 4?

The Form 4 reports two purchases totaling 1,565 shares: 686 shares at a weighted average price of $641.996 and 879 shares at $642.586, executed on 08/12/2025.

How did Fyrwald's beneficial ownership change after the reported transactions?

Beneficial ownership is reported as 73,698.779 shares after the first purchase and 74,577.779 shares after the second purchase.

Are the reported prices exact transaction prices on the Form 4?

The Form 4 states the prices are weighted averages across multiple executions and provides execution price ranges; the filer offers to supply per-price details on request.

Did the filing report any derivative or option transactions?

No. Table II for derivative securities contains no entries; only non-derivative common stock purchases are reported.

Who signed or authorized the Form 4 filing on behalf of the reporting person?

The filing indicates authorization by /s/ Jonathan Groff for J. Erik Fyrwald, pursuant to authorization on file.